Venture startup

Who invested in SerImmune

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$12Mraised across 1 round since 2020, from 1 source

Latest round
Venture, $12MSept 2020
Investors
1
See who backed them

The rounds

  1. Sept 2020
    Venture$12M

    Source recordedSEC filing: $12M sold, first sale Aug 2020

Founders and team

From the SEC filings it signed: 1 on the team.

  • Malek FahamExecutive Officer, Directori

On the board, as filediBill WelchKirstin LoomisNicholas Naclerio

Everyone who backed them

Illumina VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about SerImmune

Who invested in SerImmune?

SerImmune's investors include Illumina Ventures.

How much has SerImmune raised?

SerImmune has raised $12M across 1 round since 2020.

When did SerImmune last raise?

SerImmune's most recent round was a Venture of $12M in Sept 2020.

What was SerImmune's biggest round?

Its most recent round, $12M in Sept 2020, is also its largest on record.

Who backed SerImmune first?

SerImmune's first round on record, in Sept 2020, was backed by Illumina Ventures.

What stage is SerImmune at?

SerImmune's latest named round is a Venture, in Sept 2020.

Companies like SerImmune

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.